Telemedicine CEO Sentenced in Massive Adderall Fraud Scheme
In a significant legal outcome highlighting the potential risks within telehealth innovations, Ruthia He, the founder and former CEO of telemedicine startup Done Global, was sentenced to six years in prison. He was also fined $1 million for orchestrating an extensive Adderall fraud scheme.
The Conviction and Sentencing
Convicted alongside David Brody, Done Global’s former clinical president, He faced serious charges in a San Francisco court. A jury found the duo guilty of two counts of conspiracy related to health care fraud and the illegal distribution of controlled substances, including Adderall. Additionally, He was convicted of conspiracy to obstruct justice.
U.S. District Judge Charles Breyer, who presided over the case, sentenced Brody to a shorter term of two years in prison, alongside a $1 million fine. The court’s decision underscores the gravity of the charges brought by the Justice Department.
The Fraudulent Scheme
The Justice Department unveiled a scheme where Done Global leveraged its technology platform and clinical protocols to illegally distribute over 37 million Adderall pills. The fraudulent activities also defrauded insurers of over $12 million. The executives aimed to construct a $1 billion enterprise by driving growth through a subscription-based prescription model, which included automatically refilled prescriptions obtained through a seamless technology platform.
According to federal prosecutors, the company spent over $40 million on social media advertising, manipulating the public into believing they had ADHD. This strategy included falsely diagnosing patients and distributing Adderall to individuals with pre-existing mental health conditions, despite warnings from the company about potential adverse effects.
Impact on Healthcare and Patients
Evidence presented at trial showed a coercive environment where doctors were pressured to diagnose ADHD during brief initial visits and prescribe stimulants against their professional judgment. Done Global’s policies included refusing to hire or firing doctors who did not partake in the conspiracy while rewarding those who did with substantial monthly payments.
The company’s auto-refill technology further minimized necessary follow-up appointments, sometimes allowing patients to go years without seeing a doctor. This lack of oversight continued even when patients faced involuntary psychiatric admissions or had deceased.
Brody’s Role and the Federal Investigation
David Brody personally wrote prescriptions for hundreds of thousands of Schedule II stimulant pills without evaluating or reviewing patient records. Alongside He, Brody submitted fraudulent pre-approval requests to insurers, falsely claiming adherence to medical guidelines and testing protocols. These actions led to over $12.3 million in payments from Medicare, Medicaid, and commercial insurers.
As investigations intensified, He attempted to obstruct justice by moving operations to China and deleting incriminating evidence. Her efforts included researching non-extradition countries, highlighting the lengths to which she went to evade accountability.
Government Response and Implications
Assistant Attorney General Colin M. McDonald emphasized the betrayal of public trust, noting that He’s business model prioritized profit over patient care. The sentence serves as a warning to digital health companies about the consequences of integrating fraud and illegal drug distribution into their growth strategies.
Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, highlighted the broader impact of such fraud on vulnerable populations and taxpayers. The case exemplifies the critical role of collaboration between agencies like the DOJ and CMS in combating healthcare fraud.
For more details on this case, visit Here.
“`
